{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:55Z","timestamp":1792784335117,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81420108028"],"award-info":[{"award-number":["81420108028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["41366002"],"award-info":[{"award-number":["41366002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hainan Province","award":["ZDKJ2016002"],"award-info":[{"award-number":["ZDKJ2016002"]}]},{"name":"Changjiang Scholars and Innovative Research Team in University","award":["IRT_15R15"],"award-info":[{"award-number":["IRT_15R15"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM103801"],"award-info":[{"award-number":["GM103801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM48677"],"award-info":[{"award-number":["GM48677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP150103990"],"award-info":[{"award-number":["DP150103990"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ARC Australian Laureate Fellowship","award":["FL150100146"],"award-info":[{"award-number":["FL150100146"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.neuropharm.2017.04.015","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T13:00:40Z","timestamp":1492174840000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["\u03b1O-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human \u03b19\u03b110 subtype"],"prefix":"10.1016","volume":"127","author":[{"given":"Dongting","family":"Zhangsun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Kaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.04.015_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamem.2013.01.019","article-title":"Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels","volume":"1828","author":"Adams","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bip.21360","article-title":"Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogs","volume":"94","author":"Armishaw","year":"2010","journal-title":"Biopolymers"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1471-4159.2012.07867.x","article-title":"Molecular basis for the differential sensitivity of rat and human alpha9alpha10 nAChRs to alpha-conotoxin RgIA","volume":"122","author":"Azam","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1124\/mol.114.096511","article-title":"Molecular interaction of alpha-conotoxin RgIA with the rat alpha9alpha10 nicotinic acetylcholine receptor","volume":"87","author":"Azam","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1085\/jgp.201311104","article-title":"Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and alpha-conotoxin Vc1.1 via GABAB receptor activation","volume":"143","author":"Berecki","year":"2014","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/chan.4.1.10281","article-title":"Analgesic alpha-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of alpha9 nicotinic receptor knockout mice","volume":"4","author":"Callaghan","year":"2010","journal-title":"Channels"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib8","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1523\/JNEUROSCI.3594-08.2008","article-title":"Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation","volume":"28","author":"Callaghan","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib9","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.271.13.7522","article-title":"A\u00a0new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors","volume":"271","author":"Cartier","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib10","article-title":"Alpha-conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors","author":"Craik","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10549-010-0821-3","article-title":"Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins","volume":"125","author":"Chen","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.lfs.2011.12.023","article-title":"New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer","volume":"91","author":"Chikova","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib13","doi-asserted-by":"crossref","first-page":"23948","DOI":"10.1074\/jbc.M112.342998","article-title":"Gamma-aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic alpha-conotoxins","volume":"287","author":"Cuny","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.peptides.2009.03.019","article-title":"Remarkable inter- and intra-species complexity of conotoxins revealed by LC\/MS","volume":"30","author":"Davis","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib15","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1523\/JNEUROSCI.23-24-08445.2003","article-title":"Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors","volume":"23","author":"Dowell","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib16","doi-asserted-by":"crossref","first-page":"48849","DOI":"10.1074\/jbc.M208842200","article-title":"A\u00a0new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity","volume":"277","author":"Dutton","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/jmbi.1998.1701","article-title":"Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability","volume":"278","author":"Gehrmann","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib18","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M110.111880","article-title":"Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors","volume":"285","author":"Grishin","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib19","doi-asserted-by":"crossref","first-page":"20275","DOI":"10.1074\/jbc.M109.015339","article-title":"Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor","volume":"284","author":"Halai","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1039\/b819311h","article-title":"Conotoxins: natural product drug leads","volume":"26","author":"Halai","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.114.096156","article-title":"Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through alpha-conotoxin Vc1.1 activation of the GABA(B) receptor","volume":"87","author":"Huynh","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib22","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkr886","article-title":"ConoServer: updated content, knowledge, and discovery tools in the conopeptide database","volume":"40","author":"Kaas","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pain.2010.09.007","article-title":"A\u00a0novel mechanism of inhibition of high-voltage activated calcium channels by alpha-conotoxins contributes to relief of nerve injury-induced neuropathic pain","volume":"152","author":"Klimis","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.111.005322","article-title":"Conus venom peptide pharmacology","volume":"64","author":"Lewis","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib25","doi-asserted-by":"crossref","first-page":"E3782","DOI":"10.1073\/pnas.1501334112","article-title":"Optimized deep-targeted proteotranscriptomic profiling reveals unexplored Conus toxin diversity and novel cysteine frameworks","volume":"112","author":"Lavergne","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pnpbp.2015.12.005","article-title":"Anti-hypersensitive effect of intramuscular administration of alphaO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain","volume":"66","author":"Li","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib27","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.toxicon.2006.07.023","article-title":"Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor","volume":"48","author":"Livett","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib29","doi-asserted-by":"crossref","first-page":"e54648","DOI":"10.1371\/journal.pone.0054648","article-title":"A\u00a0novel inhibitor of alpha9alpha10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib30","doi-asserted-by":"crossref","first-page":"E4026","DOI":"10.1073\/pnas.1503617112","article-title":"Cloning, synthesis, and characterization of alphaO-conotoxin GeXIVA, a potent alpha9alpha10 nicotinic acetylcholine receptor antagonist","volume":"112","author":"Luo","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bcp.2009.05.020","article-title":"Alpha9 nicotinic acetylcholine receptors and the treatment of pain","volume":"78","author":"McIntosh","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib32","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M504102200","article-title":"A\u00a0novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors","volume":"280","author":"McIntosh","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-10-64","article-title":"alpha9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia","volume":"10","author":"Mohammadi","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib34","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.3390\/toxins7103916","article-title":"Conotoxin interactions with alpha9alpha10-nAChRs: is the alpha9alpha10-nicotinic acetylcholine receptor an important therapeutic target for pain management?","volume":"7","author":"Mohammadi","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.107.040568","article-title":"Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?","volume":"72","author":"Nevin","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mollus\/eyu055","article-title":"One, four or 100 genera? A new classification of the cone snails","volume":"81","author":"Puillandre","year":"2015","journal-title":"J.\u00a0Molluscan. Stud."},{"issue":"10","key":"10.1016\/j.neuropharm.2017.04.015_bib47","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1073\/pnas.1621433114","article-title":"Inhibition of \u03b19\u03b110 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain","volume":"114","author":"Romero","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2005.08.009","article-title":"Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones","volume":"1059","author":"Satkunanathan","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ympev.2016.10.008","article-title":"Beyond Conus: phylogenetic relationships of Conidae based on complete mitochondrial genomes","volume":"107","author":"Uribe","year":"2017","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib40","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1021\/cb4002393","article-title":"Dicarba alpha-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors","volume":"8","author":"van Lierop","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib41","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.0608715103","article-title":"Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors","volume":"103","author":"Vincler","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib42","doi-asserted-by":"crossref","first-page":"30664","DOI":"10.1074\/jbc.274.43.30664","article-title":"The T-superfamily of conotoxins","volume":"274","author":"Walker","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib43","doi-asserted-by":"crossref","unstructured":"Wright, A. B., Norimatsu, Y., McIntosh, J. M., Elmslie, K. S., 2015. Limited efficacy of alpha-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron CaV current. eNeuro 2.0057\u201314.","DOI":"10.1523\/ENEURO.0057-14.2015"},{"key":"10.1016\/j.neuropharm.2017.04.015_bib44","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-10-2434","article-title":"Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy","volume":"17","author":"Wu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib45","doi-asserted-by":"crossref","first-page":"14261","DOI":"10.1038\/srep14261","article-title":"Conotoxin alphaD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.04.015_bib46","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1021\/jm400041h","article-title":"Determination of the alpha-conotoxin Vc1.1 binding site on the alpha9alpha10 nicotinic acetylcholine receptor","volume":"56","author":"Yu","year":"2013","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:52:56Z","timestamp":1758437576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817301569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":47,"alternative-id":["S0028390817301569"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1O-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human \u03b19\u03b110 subtype","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}